average glp 1 dose New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks GLP-1 receptor agonists Doses available
Description
Liraglutide-loaded microspheres have shown promise for sustained drug release over 1 month
A head-to-head comparison revealed that both semaglutide and tirzepatide reduced the composite risk of hospitalization for HF or all-cause mortality by over 40% relative to placebo, with no significant advantage of tirzepatide over semaglutide
Also a solid starting point for patients new to peptide-based metabolic therapy
Half the conversation is happening outside the exam room, and a lot of patients show up already down a rabbit hole of protocols and stories
